RVPH On behalf of Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH), Chief Executive Officer, Dr. Laxminarayan Bhat, composed a letter to shareholders acknowledging the difficult path over the last ...

Hydreight (HYDTF) has transformed into a 50-state healthcare infrastructure company, rapidly scaling VSDHOne licenses to 11K+ ...

Predicting Bioequivalence During Generic Drug Formulation. Small variations in formulation can affect bioequivalence. However ...

Companies that make compounded drugs obtain semaglutide API from authorized and registered chemical manufacturers.

RT-MALS can provide instantaneous measurements of adenovirus particle size and titer during downstream and fill–finish ...

Caplin Point is consolidating for growth, eyeing expansion in Latin America and the US with strong future potential.

Patent expiry has slashed semaglutide prices in India by up to 90%, but regulatory hurdles and newer drugs mean the global ...

As geopolitics bring reshoring interest to a fever pitch, the United States Pharmacopeia (USP) is adding to the impetus for ...

Cautionary Language Concerning Forward-Looking Statements ...

In a complex therapeutic landscape, WuXi AppTec is simplifying the path from discovery to patient. Find out how.

Raman spectroscopy enables detailed comparison of coating composition and uniformity between RLD and generic pellets.

Explore modern identity-based attacks and how to defend against them using Zero Trust. Define and differentiate between ...